December 14, 2017 05:14 PM ESTUpdated 05:28 PM
Financing
Startups

Jnana launch­es with $50M to spot­light an un­ex­plored pro­tein ter­ri­to­ry

Brittany Meiling

Boston start­up Jnana Ther­a­peu­tics is launch­ing with a $50 mil­lion Se­ries A round to de­vel­op a drug dis­cov­ery plat­form it hopes will push the en­ve­lope …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times